NASDAQ$TECH
Bio-Techne Corp · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
Bio-Techne team delivered strong organic growth and profitability.
Bio-Techne reported a strong fourth quarter with a 39% increase in organic revenue and an adjusted operating margin of 38.5%. The company's Protein Sciences and Diagnostics and Genomics segments achieved record organic growth. Management sees continued momentum as they penetrate the life science markets.
- Fourth quarter organic revenue increased by 39% (47% reported) to $259.0 million.
- GAAP EPS was $0.37 versus $1.48 one year ago. Adjusted EPS of $1.87 versus $1.00 one year ago.
- Adjusted Operating Margin increased to 38.5% in the fourth quarter of fiscal 2021 compared to 31.1% in the fourth quarter of fiscal 2020.
- Protein Sciences and Diagnostics and Genomics achieving record organic growth of 46% and 22%, respectively.
Headline financials
Revenue & EPS history
Bio-Techne · Revenue · Quarterly
$259M
Revenue by segment
Bio-Techne · $192M total across 1 segment · Q4 2021
- Protein Sciences$192M+51.1%100.0%
Forward guidance
Bio-Techne sees continued momentum as they increase their penetration into the life science markets they serve, and their businesses reach and exceed the tipping points in size necessary to accelerate growth.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2021
+0.8%
Avg return
Earnings day
+1.0%
Avg return
5 days after
+1.8%
Avg return
30 days after
58%
39 / 67 earnings
Positive
+19.6%
Q3 2024
Best reaction
-9.0%
Q1 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | +0.0% | -18.3% | -8.1% | |
| Q2 2026 | +4.8% | +1.3% | -16.6% | |
| Q1 2026 | -1.9% | -6.0% | +0.9% | |
| Q3 2025 | +2.2% | +13.0% | +2.0% | |
| Q2 2025 | +3.7% | -3.6% | -11.3% | |
| Q1 2025 | +4.3% | +7.3% | +6.5% | |
| Q4 2024 | -6.4% | -8.5% | -8.8% | |
| Q3 2024 | +19.6% | +20.3% | +22.1% | |
| Q2 2024 | -6.2% | -4.2% | +5.8% | |
| Q1 2024 | -6.7% | +3.7% | +11.1% | |
| Q4 2023 | +2.1% | +3.8% | -9.0% | |
| Q3 2023 | +4.8% | +2.6% | +3.5% | |
| Q2 2023 | -2.6% | -3.5% | -3.7% | |
| Q1 2023 | +0.6% | +2.5% | +16.7% | |
| Q4 2022 | -2.3% | -7.8% | -15.8% | |
| Q3 2022 | +0.7% | -9.5% | -5.3% | |
| Q2 2022 | +11.0% | +8.9% | +11.5% | |
| Q1 2022 | -3.9% | -5.3% | -11.0% | |
| Q4 2021 | -1.0% | -4.7% | +5.4% | |
| Q3 2021 | +1.5% | -0.3% | +1.8% | |
| Q2 2021 | +8.3% | +11.9% | +2.3% | |
| Q1 2021 | +13.2% | +12.4% | +14.8% | |
| Q4 2020 | -3.9% | -4.7% | -10.1% | |
| Q3 2020 | +7.7% | +16.5% | +25.4% | |
| Q2 2020 | -0.3% | -3.0% | -6.4% | |
| Q1 2020 | +0.0% | +0.6% | +6.1% | |
| Q4 2019 | -4.6% | -3.7% | -4.8% | |
| Q3 2019 | +3.0% | +4.8% | -0.7% | |
| Q2 2019 | +5.3% | +3.3% | +7.3% | |
| Q1 2019 | -5.5% | -4.1% | -8.5% | |
| Q4 2018 | +5.0% | +5.8% | +12.8% | |
| Q3 2018 | -2.8% | -1.4% | +0.1% | |
| Q2 2018 | +3.0% | +0.8% | +8.6% | |
| Q1 2018 | +3.8% | +4.6% | +9.0% | |
| Q4 2017 | -1.5% | +1.1% | +3.8% | |
| Q3 2017 | +2.0% | +3.0% | +5.3% | |
| Q2 2017 | -1.0% | +2.3% | +6.2% | |
| Q1 2017 | +0.3% | -1.6% | +4.3% | |
| Q4 2016 | -3.4% | -2.8% | -2.6% | |
| Q3 2016 | +7.1% | — | — | |
| Q2 2016 | +4.9% | — | — | |
| Q1 2016 | -9.0% | — | — | |
| Q4 2015 | -2.3% | — | — | |
| Q3 2015 | +1.6% | — | — | |
| Q2 2015 | -3.2% | — | — | |
| Q1 2015 | -2.8% | — | — | |
| Q4 2014 | +0.2% | — | — | |
| Q3 2014 | +8.1% | — | — | |
| Q2 2014 | -4.4% | — | — | |
| Q1 2014 | +0.7% | — | — | |
| Q4 2013 | +4.1% | — | — | |
| Q3 2013 | +0.4% | — | — | |
| Q2 2013 | -2.2% | — | — | |
| Q1 2013 | -4.3% | — | — | |
| Q4 2012 | -3.8% | — | — | |
| Q3 2012 | +0.5% | — | — | |
| Q2 2012 | +2.2% | — | — | |
| Q1 2012 | -5.3% | — | — | |
| Q4 2009 | +1.4% | — | — | |
| Q4 2011 | +1.4% | — | — | |
| Q3 2011 | +0.5% | — | — | |
| Q3 2010 | +0.5% | — | — | |
| Q2 2011 | -0.8% | — | — | |
| Q1 2011 | +0.6% | — | — | |
| Q4 2010 | +0.6% | — | — | |
| Q1 2010 | +0.6% | — | — | |
| Q2 2010 | +0.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro